{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T15:40:40Z","timestamp":1783438840749,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-02167\u201321"],"award-info":[{"award-number":["APQ-02167\u201321"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.actatropica.2023.106986","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T21:21:09Z","timestamp":1689283269000},"page":"106986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice"],"prefix":"10.1016","volume":"246","author":[{"given":"Daniela P.","family":"Lage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00edvian T.","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danniele L.","family":"Vale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7882-215X","authenticated-orcid":false,"given":"Camila S.","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Breno L.","family":"Pimenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J.L.","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda F.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela A.G.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel S.","family":"Bandeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo M.","family":"de Jesus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Ludolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grasiele S.V.","family":"Tavares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Ch\u00e1vez-Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno M.","family":"Roatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9663-4731","authenticated-orcid":false,"given":"Myron","family":"Christodoulides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo A.F.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2023.106986_bib0001","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.imlet.2021.03.011","article-title":"Immunotherapy in treatment of leishmaniasis","volume":"233","author":"Akbari","year":"2021","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.actatropica.2023.106986_bib0002","first-page":"238","article-title":"Immune response to Leishmania infection","volume":"119","author":"Awasthi","year":"2004","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2023.106986_bib0003","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.vaccine.2009.09.071","article-title":"Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis","volume":"28","author":"Borja-Cabrera","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2023.106986_bib0004","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet."},{"key":"10.1016\/j.actatropica.2023.106986_bib0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1590\/0037-8682-0138-2015","article-title":"New delivery systems for amphotericin B applied to the improvement of leishmaniasis treatment","volume":"48","author":"Ch\u00e1vez-Fumagalli","year":"2015","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2023.106986_bib0006","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.1128\/IAI.71.7.3988-3994.2003","article-title":"Immune responses induced by the Leishmania (Leishmania) donovani A2 antigen, but not by the LACK antigen, are protective against experimental Leishmania (Leishmania) amazonensis infection","volume":"71","author":"Coelho","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actatropica.2023.106986_bib0008","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.4049\/jimmunol.166.6.4020","article-title":"Successful therapy of lethal murine visceral leishmaniasis with cystatin involves up-regulation of nitric oxide and a favorable T cell response","volume":"166","author":"Das","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0009","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1007\/s00436-018-6032-2","article-title":"Biomarkers and renal arterial resistive index in dogs naturally infected with Leishmania infantum","volume":"117","author":"Frazilio","year":"2018","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2023.106986_bib0010","doi-asserted-by":"crossref","first-page":"893","DOI":"10.4049\/jimmunol.167.2.893","article-title":"Oxidative responses of human and murine macrophages during phagocytosis of Leishmania chagasi","volume":"167","author":"Gantt","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0011","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/meth.2001.1261","article-title":"An overview of real-time quantitative PCR: applications to quantify cytokine gene expression","volume":"25","author":"Giulietti","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.actatropica.2023.106986_bib0012","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijpara.2012.02.013","article-title":"A novel recombinant Leishmania donovani p45, a partial coding region of methionine aminopeptidase, generates protective immunity by inducing a Th1 stimulatory response against experimental visceral leishmaniasis","volume":"42","author":"Gupta","year":"2012","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0013","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.exppara.2015.03.027","article-title":"Evaluation of adjuvant activity of fractions derived from Agaricus blazei, when in association with the recombinant LiHyp1 protein, to protect against visceral leishmaniasis","volume":"153","author":"Jesus-Pereira","year":"2015","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0014","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jmii.2022.06.003","article-title":"Combined immunotherapeutic effect of Leishmania-derived recombinant aldolase and Ambisome against experimental visceral leishmaniasis","volume":"56","author":"Keerti","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.actatropica.2023.106986_bib0015","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.4049\/jimmunol.144.7.2529","article-title":"IgG1 and IgG2a production by autoimmune B cells treated in vitro with IL-4 and IFN-gamma","volume":"144","author":"Klinman","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0016","doi-asserted-by":"crossref","first-page":"5700","DOI":"10.1016\/j.vaccine.2008.08.021","article-title":"Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa offers long-lasting protection against experimental visceral leishmaniasis","volume":"26","author":"Kumari","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2023.106986_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106661","article-title":"Amphotericin B: a drug of choice for visceral leishmaniasis","volume":"235","author":"Kumari","year":"2022","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2023.106986_bib0018","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.actatropica.2018.03.016","article-title":"Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: a literature review","volume":"182","author":"Mosimann","year":"2018","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2023.106986_bib0019","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.3390\/vaccines10071146","article-title":"A recombinant chimeric protein-based vaccine containing T-cell epitopes from amastigote proteins and combined with distinct adjuvants, induces immunogenicity and protection against Leishmania infantum infection","volume":"10","author":"Lage","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.actatropica.2023.106986_bib0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","article-title":"The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice","volume":"20","author":"Lehmann","year":"2000","journal-title":"J. Int. Cyt. Res."},{"key":"10.1016\/j.actatropica.2023.106986_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2022.106412","article-title":"A recombinant Leishmania amastigote-specific protein, rLiHyG, with adjuvants, protects against infection with Leishmania infantum","volume":"230","author":"Machado","year":"2022","journal-title":"Acta Trop"},{"key":"10.1016\/j.actatropica.2023.106986_bib0022","doi-asserted-by":"crossref","first-page":"e2148","DOI":"10.1371\/journal.pntd.0002148","article-title":"Antigenicity and protective efficacy of a Leishmania amastigote-specific protein, member of the super-oxygenase family, against visceral leishmaniasis","volume":"7","author":"Martins","year":"2013","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2023.106986_bib0023","article-title":"Antigenicity, immunogenicity and protective efficacy of three proteins expressed in the promastigote and amastigote stages of Leishmania infantum against visceral leishmaniasis","volume":"10","author":"Martins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.actatropica.2023.106986_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108969","article-title":"Immunotherapy for visceral leishmaniasis: a trapeze of balancing counteractive forces","volume":"110","author":"Mazire","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/qjmed\/hct116","article-title":"Leishmaniasis: clinical syndromes and treatment","volume":"107","author":"Mc Gwire","year":"2014","journal-title":"QJM"},{"key":"10.1016\/j.actatropica.2023.106986_bib0026","first-page":"922","article-title":"Immunogenicity and protection effects of cationic liposome containing imiquimod adjuvant on leishmaniasis in BALB\/c mice","volume":"22","author":"Mehravaran","year":"2019","journal-title":"Iran J. Basic Med. Sci."},{"key":"10.1016\/j.actatropica.2023.106986_bib0027","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1080\/08982104.2017.1376682","article-title":"Liposomal formulations in the pharmacological treatment of leishmaniasis: a review","volume":"27","author":"Ortega","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.actatropica.2023.106986_bib0028","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.bbrc.2010.07.099","article-title":"Amphotericin B inhibits entry of Leishmania donovani into primary macrophages","volume":"399","author":"Paila","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.actatropica.2023.106986_bib0029","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/eji.201242428","article-title":"TLR-mediated distinct IFN-\u03b3\/IL-10 pattern induces protective immunity against murine visceral leishmaniasis","volume":"42","author":"Paul","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006052","article-title":"Drug resistance and treatment failure in leishmaniasis: a 21st century challenge","volume":"11","author":"Ponte-Sucre","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2023.106986_bib0031","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/ced.14919","article-title":"Treatment options for leishmaniasis","volume":"47","author":"Pradhan","year":"2022","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0032","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1128\/AAC.00030-11","article-title":"Mechanism of amphotericin B resistance in clinical isolates of Leishmania donovani","volume":"56","author":"Purkait","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2023.106986_bib0033","first-page":"5341","article-title":"An optimized nanoparticle delivery system based on chitosan and chondroitin sulfate molecules reduces the toxicity of amphotericin B and is effective in treating tegumentary leishmaniasis","volume":"9","author":"Ribeiro","year":"2014","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.actatropica.2023.106986_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155031","article-title":"Leishmania infantum amastin protein incorporated in distinct adjuvant systems induces protection against visceral leishmaniasis","volume":"129","author":"Ribeiro","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.actatropica.2023.106986_bib0035","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fimmu.2014.00272","article-title":"Immunotherapy and immunochemotherapy in visceral leishmaniasis: promising treatments for this neglected disease","volume":"5","author":"Roatt","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0036","doi-asserted-by":"crossref","first-page":"6176","DOI":"10.1016\/j.vaccine.2007.06.005","article-title":"Immunotherapy against experimental canine visceral leishmaniasis with the saponin enriched-Leishmune vaccine","volume":"25","author":"Santos","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.actatropica.2023.106986_bib0037","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.4049\/jimmunol.140.7.2121","article-title":"IFN-gamma stimulates IgG2a secretion by murine B cells stimulated with bacterial lipopolysaccharide","volume":"140","author":"Snapper","year":"1988","journal-title":"J. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0038","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/pathogens12020314","article-title":"Immunotherapy using immunogenic mimotopes selected by phage display plus amphotericin B inducing a therapeutic response in mice infected with Leishmania amazonensis","volume":"12","author":"Soyer","year":"2023","journal-title":"Pathogens"},{"key":"10.1016\/j.actatropica.2023.106986_bib0039","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2023.106986_bib0040","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/infdis\/170.3.659","article-title":"Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma","volume":"170","author":"Sundar","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2023.106986_bib0041","article-title":"A specific Leishmania infantum polyepitope vaccine triggers Th1-type immune response and protects against experimental visceral leishmaniasis","volume":"380","author":"Valentim","year":"2022","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.actatropica.2023.106986_bib0042","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00436-001-0577-0","article-title":"Histopathologic analysis of hamster hepatocytes submitted to experimental infection with Leishmania donovani","volume":"88","author":"Vianna","year":"2002","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.actatropica.2023.106986_bib0043","series-title":"Leishmaniasis","year":"2022"},{"key":"10.1016\/j.actatropica.2023.106986_bib0044","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/17460441.2022.2002843","article-title":"Assay development in leishmaniasis drug discovery: a comprehensive review","volume":"17","author":"Zulfiqar","year":"2022","journal-title":"Expert Opin. Drug Discov."}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X23001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X23001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:43:39Z","timestamp":1757551419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X23001730"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":43,"alternative-id":["S0001706X23001730"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.106986","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The association between rLiHyp1 protein plus adjuvant and amphotericin B is an effective immunotherapy against visceral leishmaniasis in mice","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2023.106986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106986"}}